BioArctic's IPO

BioArctic raised a round of funding on October 12, 2017. Investors include Public.

BioArctic is a Swedish biopharma company specialized in developing treatments that address the causes of diseases that affect the Central Nervous System. The company develops biological drugs with the…

Articles about BioArctic's IPO: